Rotavirus vaccine still effective in reducing diarrhea-related deaths in Mexico, researchers say

"The rotavirus vaccine introduced in Mexico in 2007 still appears to be preventing diarrhea-related deaths in children, despite speculation that years later the vaccine may not be as effective," according to the Los Angeles Times' "Booster Shots" blog. "In a letter released Wednesday in the New England Journal of Medicine, researchers report that the vaccine still seems to be successful in reducing mortality rates among children," the blog writes, adding that rotavirus "is responsible for 527,000 childhood deaths per year" worldwide.

The authors "compared diarrhea-related deaths during the three years after the vaccine was introduced with death rates during rotavirus seasons from 2003 to 2006," noting "that the decrease in death rates due to diarrhea continued for three seasons after the vaccine was introduced shows that some of the drop in mortality rates is probably due to the vaccinations," according to the blog (Stein, 8/25).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    WHO grants Emergency Use Listing for LC16m8 mpox vaccine